QA: Amicus Therapeutics INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2017_Amicus_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178879, Amicus Therapeutics INC

  xvar xval
0 AssetsCurrent 340,064,000
1 IntangibleAssetsNetIncludingGoodwill 684,497,000
2 PropertyPlantAndEquipmentNet 9,816,000
3 remainder_Assets 2,468,000
4 LiabilitiesCurrent 110,959,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 105,160,242
9 ResearchAndDevelopmentExpense 114,403,343
10 remainder_Expenses 17,934,652
11 remainder_Revenues 3,269,392
12 remainder_NetIncome -97,773,997
13 remainder_ComprehensiveNetIncome 12,845,750
  yvar yval
0 Assets 1,036,845,000
1 Liabilities 110,959,000
2 Expenses 237,498,237
3 Revenues 3,269,392
4 StockholdersEquity 925,886,000
5 NetIncome -332,002,842
6 ComprehensiveNetIncome -325,579,967
7 BaseVar 749,595,688
8 EconomicCapitalRatiobeforeLimitedLiability 2.95
9 EconomicCapitalRatio 3.65

Edgar->Model Mapping

Feature Distribution

Change over Time